PENNISI, MARIA STELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.630
EU - Europa 1.074
AS - Asia 841
SA - Sud America 209
AF - Africa 182
OC - Oceania 3
Totale 3.939
Nazione #
US - Stati Uniti d'America 1.584
RU - Federazione Russa 457
SG - Singapore 404
IT - Italia 269
BR - Brasile 185
CN - Cina 163
CI - Costa d'Avorio 114
VN - Vietnam 105
IE - Irlanda 97
IN - India 57
DE - Germania 55
GB - Regno Unito 35
SN - Senegal 35
FR - Francia 31
CA - Canada 28
FI - Finlandia 24
JP - Giappone 15
SE - Svezia 15
BE - Belgio 13
ES - Italia 13
MX - Messico 13
PL - Polonia 13
ZA - Sudafrica 13
IQ - Iraq 11
KR - Corea 11
AR - Argentina 10
HK - Hong Kong 10
NG - Nigeria 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
TR - Turchia 9
BD - Bangladesh 8
UA - Ucraina 8
NL - Olanda 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
ID - Indonesia 5
NO - Norvegia 5
PK - Pakistan 5
SA - Arabia Saudita 5
CH - Svizzera 4
MA - Marocco 4
AU - Australia 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
GR - Grecia 3
IL - Israele 3
KE - Kenya 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
AT - Austria 2
CO - Colombia 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
MY - Malesia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CY - Cipro 1
GD - Grenada 1
HR - Croazia 1
KG - Kirghizistan 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
NP - Nepal 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.939
Città #
Singapore 274
Moscow 223
Dallas 218
Santa Clara 218
Chandler 194
San Jose 119
Abidjan 114
Ashburn 103
Chicago 101
Dublin 97
Catania 64
Beijing 52
Los Angeles 51
Civitanova Marche 34
Dakar 34
Council Bluffs 32
Kochi 32
Boardman 31
New York 29
Cambridge 27
Ho Chi Minh City 27
Lauterbourg 25
Lawrence 25
Andover 24
Grafing 23
Dong Ket 22
Hanoi 18
São Paulo 18
Wilmington 17
Munich 16
Montreal 15
Palermo 15
The Dalles 15
Tokyo 15
Des Moines 14
Brussels 13
Buffalo 13
Columbus 13
Johannesburg 12
Turku 12
Hefei 11
Seoul 11
Belo Horizonte 10
Chennai 10
Nanjing 10
Orem 10
Bari 9
Helsinki 9
Santa Venerina 9
Warsaw 9
Brno 8
Milan 8
Toronto 8
Hong Kong 7
Houston 7
London 7
Rio de Janeiro 7
Seattle 7
Frankfurt am Main 6
Lagos 6
Manchester 6
Pune 6
Tashkent 6
Aci Catena 5
Denver 5
Haiphong 5
Amsterdam 4
Baghdad 4
Bremen 4
Budapest 4
Edinburgh 4
Falls Church 4
Giardini-Naxos 4
Jiaxing 4
Oslo 4
Poplar 4
Querétaro 4
Saint Petersburg 4
San Giovanni la Punta 4
Stockholm 4
Tremestieri Etneo 4
Asunción 3
Atlanta 3
Boston 3
Casablanca 3
Catanzaro 3
Elk Grove Village 3
Fantina 3
Guarulhos 3
Hanover 3
Jacksonville 3
Jakarta 3
Jeddah 3
Jinan 3
Lappeenranta 3
Madrid 3
Manaus 3
Messina 3
Mexico City 3
Mumbai 3
Totale 2.718
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 227
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 191
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 180
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 169
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 167
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 164
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 160
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 159
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 158
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 156
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 156
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 153
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 153
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 147
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 145
New insights in thyroid cancer and p53 family proteins 138
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 130
Opportunities and challenges of liquid biopsy in thyroid cancer 129
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 126
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 126
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 119
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 118
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 116
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 112
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 109
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 108
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis 104
The Role of New Technologies in Myeloproliferative Neoplasms 90
Totale 4.010
Categoria #
all - tutte 12.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.857


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 0 0 0 0 0 3 27
2021/2022184 1 33 6 3 37 4 30 6 7 1 12 44
2022/2023515 29 46 23 68 28 75 3 108 98 5 23 9
2023/2024299 21 49 11 9 10 76 2 19 2 11 68 21
2024/2025959 13 154 38 87 187 132 97 30 31 46 113 31
2025/20261.810 97 94 230 127 277 505 165 18 136 136 25 0
Totale 4.010